Multivariate data analysis for the detection of human alpha-acid glycoprotein aberrant glycosylation in pancreatic ductal adenocarcinoma

Publication date

2022-06-21T07:04:39Z

2022-06-21T07:04:39Z

2019

2022-06-21T07:04:39Z

Abstract

Relative quantification of human alpha-acid glycoprotein (hAGP) glycan isomers using [12C6]/[13C6]-aniline in combination with multivariate data analysis is proposed as an efficient method for the identification of pancreatic ductal adenocarcinoma (PDAC) glycan biomarkers in serum samples. Intact and desialylated glycans from hAGP, purified from serum samples of patients with PDAC and chronic pancreatitis (ChrP), were labeled with aniline and analyzed by μZIC-HILIC-MS. Afterwards, partial least squares discriminant analysis (PLS-DA) was applied to the relative areas obtained for all glycan isomers in the different samples: pathological (ChrP or PDAC) versus healthy samples. Seven intact glycan isomers with α2-6 linked sialic acids, five of them also fucosylated, were the most meaningful to distinguish between PDAC and ChrP patients. The desialylated glycan isomers also identified by PLS-DA as potential biomarker candidates confirmed that antenna but also core fucosylation could be involved in PDAC. The analysis of intact and desialylated glycan isomers in combination with the multivariate data analysis revealed that the triantennary glycan with two fucoses of hAGP could have in the future a relevant role in the differentiation of patients with PDAC from those with ChrP.

Document Type

Article


Accepted version

Language

English

Publisher

Elsevier B.V.

Related items

Versió postprint del document publicat a: https://doi.org/10.1016/j.jprot.2019.01.006

Journal of Proteomics, 2019, vol. 195, p. 76-87

https://doi.org/10.1016/j.jprot.2019.01.006

Recommended citation

This citation was generated automatically.

Rights

cc-by-nc-nd (c) Elsevier B.V., 2019

https://creativecommons.org/licenses/by-nc-nd/4.0/

This item appears in the following Collection(s)